Predicting Outcome in Pollen Immuno Therapy

Predicting Outcome in Pollen Immuno Therapy - the POPIT-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36093

Enrollment

Registered

2011-11-07

Start date

2012-03-30

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hay fever pollenosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Clinical relevant allergic rhinitis complaints caused by grass pollen

Exclusion criteria

Exclusion criteria: Immunodeficiencies Pregnancy Severe heart and vasculair diseases Renal failure

Design outcomes

Primary

Measure	Time frame
The differences between the expression at the RNA level in nasal mucosa and the possibility to predict the effect of immunotherapy with specific expression profiles.	—

Secondary

Measure	Time frame
VAS score during nasal provocation before and after immunotherapy Quantitative skin prick test before and after immunotherapy	—

Countries

Netherlands

Outcome results